v3.26.3
Fair Value Measurements - Additional Information (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
May 01, 2026
Aug. 27, 2025
Feb. 24, 2025
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Fair value, assets and liabilities, transfers between level 1, 2 and 3 amount $ 0   $ 0   $ 0      
Impairment losses on its investments 0 $ 0 0 $ 0        
Series A Preferred Stock                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Change in fair value     0          
Series A Preferred Stock | Second Tranche                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Fair value price per share             $ 20.62  
Change in fair value       1,100,000        
Series A Preferred Stock | Third Tranche                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Change in fair value       0        
PhysIQ, Inc.                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Fair value of contingent milestone 4,000,000   4,000,000   3,900,000     $ 3,300,000
Business combination, contingent milestone payments 0   0          
PhysIQ, Inc. | Maximum                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Business combination, contingent milestone payments               20,000,000
Prolaio, Inc.                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Change in fair value     21,740,000 $ 0        
Fair value of contingent milestone $ 25,600,000   $ 25,600,000   $ 3,800,000 $ 13,700,000   4,600,000
Prolaio, Inc. | Maximum                
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                
Business combination, contingent milestone payments               $ 200,000,000